BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 25, 2025.

via HealthDay

WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), according to a study published online June 12 in Blood Advances.

Paola Ghione, M.D., from Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined the risk of BIA-ALCL occurrence related to BRCA in a large population of women with textured implants followed after BC mastectomy. The prevalence of BRCA1/2 was compared between BC patients who did and did not develop BIA-ALCL after reconstruction with textured implants. Cox regression was used to estimate hazard ratios for developing BIA-ALCL. In addition, a case–control study was conducted involving 13 cases with BIA-ALCL and 39 controls.

The researchers found that the age-adjusted rate of developing BIA-ALCL was 16 times higher for women with versus without BRCA among 520 patients with BC tested for BRCA. No associations were seen for carrying bilateral implants, chemotherapy, or radiation therapy with BIA-ALCL. A complete enumeration of Bernoulli probability was used to rule out a nonassociation of BRCA with BIA-ALCL in the case–control study.

"If we look at the absolute numbers [seen in this study], it's still fairly rare, but the important thing to note is that when we look at women with this genetic predisposition, there is a big jump in the percentage with this lymphoma," Ghione said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords